Literature DB >> 7746172

Is there any value in bimanual pelvic examination as a screening test.

S R Grover1, M A Quinn.   

Abstract

OBJECTIVES: To assess the place of bimanual pelvic examination as a routine procedure in healthy women.
METHODS: 2623 healthy, asymptomatic volunteers (mean age, 51 years; range, 25-92 years) underwent pelvic examination as part of an ovarian cancer screening program. The presence of a bulky or fibroid uterus and adnexal abnormality was noted. Pelvic ultrasonography was used to investigate adnexal abnormalities and was also performed in all women with an elevated serum CA-125 antigen level (> 35 U/mL). Laparoscopy or laparotomy was performed as clinically indicated.
RESULTS: A bulky or fibroid uterus was detected in 12.9% of women. The prevalence of abnormal adnexal findings was 1.5%, with a positive predictive value for a subsequent diagnosis of benign adnexal abnormality of 22%. The specificity of vaginal examination for malignancy was 99.9%. No ovarian malignancies were identified at initial screening.
CONCLUSIONS: This "routine" procedure is undertaken in the belief that it serves a screening purpose. The detection of benign uterine abnormality is of no clear benefit as progression to malignancy is rare. Bimanual pelvic examination is of questionable value as a screening strategy in view of the low incidence of ovarian cancer in healthy women, and the relatively high prevalence (1.5%) of relatively unimportant adnexal abnormalities.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7746172

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  4 in total

1.  A prospective observational study of lower urinary tract symptoms before and after surgical removal of a large pelvic mass.

Authors:  Kristina Cvach; Peter Dwyer; Anna Rosamilia; Yik Lim; Lore Schierlitz
Journal:  Int Urogynecol J       Date:  2014-07-16       Impact factor: 2.894

2.  Recommendations on routine screening pelvic examination: Canadian Task Force on Preventive Health Care adoption of the American College of Physicians guideline.

Authors:  Marcello Tonelli; Sarah Connor Gorber; Ainsley Moore; Brett D Thombs
Journal:  Can Fam Physician       Date:  2016-03       Impact factor: 3.275

3.  A xenograft mouse model coupled with in-depth plasma proteome analysis facilitates identification of novel serum biomarkers for human ovarian cancer.

Authors:  Hsin-Yao Tang; Lynn A Beer; Tony Chang-Wong; Rachel Hammond; Phyllis Gimotty; George Coukos; David W Speicher
Journal:  J Proteome Res       Date:  2011-11-18       Impact factor: 4.466

4.  Women's attitudes and expectations regarding gynaecological examination.

Authors:  Emre Yanikkerem; Meral Ozdemir; Hilal Bingol; Ayşe Tatar; Gülten Karadeniz
Journal:  Midwifery       Date:  2007-12-20       Impact factor: 2.372

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.